Concepedia

Nancy François

NF

11

Publications

394

Citations

11

H-Index

2011

Active since

Affiliations

GlaxoSmithKline (Belgium)(Current)

University of Bamako

University Medical Center Utrecht

Wilhelmina Children's Hospital

Nancy François is an author at GlaxoSmithKline (Belgium) specializing in vaccine development, infection control, and medicine.

ORCID

Top concepts

Publications per year

2011–2017

11

Publications

11

Effects of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugate Vaccine on Nasopharyngeal Bacterial Colonization in Young Children: A Randomized Controlled Trial

Menno R. van den Bergh, Judith Spijkerman, Kristien Swinnen et al. · Clinical Infectious Diseases · 2012 · 133 citations · Full text

Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol

Roman Prymula, Ahsan Habib, Nancy François et al. · Vaccine · 2013 · 46 citations

Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands

Menno R. van den Bergh, Judith Spijkerman, Nancy François et al. · The Pediatric Infectious Disease Journal · 2011 · 42 citations

Immunization of Preterm Infants With 10-Valent Pneumococcal Conjugate Vaccine

Félix Omeñaca, José Merino, Juan Carlos Tejedor Torres et al. · PEDIATRICS · 2011 · 41 citations

Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children

Rosanna Lagos, Alma Muñoz, Myron M. Levine et al. · Human Vaccines · 2011 · 30 citations · Full text

, , +16

Rows per page

1–5 of 11